A股异动 | 海特生物午间大幅收跌8.72% Q3归母净利润亏损1.19亿元

Core Points - HaiTe Bio experienced a significant decline of 8.72% in stock price, reaching a new low of 31.5 yuan, with a cumulative drop of over 46% since late August, resulting in a market capitalization of 4.126 billion yuan [1] Financial Performance - For the first three quarters of 2025, HaiTe Bio reported operating revenue of 422 million yuan, a year-on-year decrease of 6.5% [1] - The company recorded a net loss attributable to shareholders of 158 million yuan, which is a substantial increase compared to the previous year's loss [1] - The net loss excluding non-recurring items also reached 180 million yuan [1] - In the third quarter alone, revenue was 147 million yuan, reflecting an 11.7% year-on-year decline, with a net loss attributable to shareholders of 119 million yuan [1] Financial Position - Financial data indicates increasing pressure on the company's funds, with cash and cash equivalents decreasing by 59.55% from the beginning of the period to the end of the third quarter [1]